Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 16, 2015

Drug Name Review Type Class Manufacturer
Praluent New Drug Initial Review Cholesterol Lowering Sanofi
Daklinza New Drug Initial Review Hepatitis C Bristol-Myers Squibb
Cosentyx New Drug Initial Review Psoriasis Novartis
Feraheme New Drug Initial Review Intravenous Iron Amag
Technivie New Drug Initial Review Hepatitis C AbbVie
Corlanor New Drug Initial Review Heart Failure Amgen
Triumeq New Drug Initial Review HIV ViiV Healthcare
Entresto New Drug Initial Review Chronic Heart Failure Novartis
Invega Trinza New Drug Initial Review Atypical Antipsychotic Janssen Pharmaceuticals